Simulations Plus Inc Sentiment Worsening on Low Stock Potential

May 26, 2018 - By Marguerite Chambers

Simulations Plus, Inc. (NASDAQ:SLP) Logo

Sentiment for Simulations Plus Inc (NASDAQ:SLP)

Simulations Plus Inc (NASDAQ:SLP) institutional sentiment decreased to 1.56 in 2017 Q4. Its down -0.50, from 2.06 in 2017Q3. The ratio fall, as 39 funds increased and started new holdings, while 25 sold and reduced their equity positions in Simulations Plus Inc. The funds in our partner’s database reported: 5.50 million shares, up from 5.43 million shares in 2017Q3. Also, the number of funds holding Simulations Plus Inc in their top 10 holdings was flat from 0 to 0 for the same number . Sold All: 6 Reduced: 19 Increased: 25 New Position: 14.

Simulations Plus, Inc. develops and sells drug discovery and development software for mechanistic modeling and simulation. The company has market cap of $341.32 million. The firm offers GastroPlus, which simulates the absorption, pharmacokinetics , and pharmacodynamics of drugs administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments, which measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments. It has a 41.83 P/E ratio. It also provides PKPlus, a standalone program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for NCA and compartmental PK modelling; ADMET Predictor, a chemistry computer program, which takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher that integrates with MedChem Studio and ADMET Predictor.

The stock increased 3.68% or $0.7 during the last trading session, reaching $19.7. About 36,209 shares traded. Simulations Plus, Inc. (NASDAQ:SLP) has risen 29.91% since May 26, 2017 and is uptrending. It has outperformed by 18.36% the S&P500.

Analysts await Simulations Plus, Inc. (NASDAQ:SLP) to report earnings on July, 9. They expect $0.13 EPS, 0.00 % or $0.00 from last year’s $0.13 per share. SLP’s profit will be $2.25M for 37.88 P/E if the $0.13 EPS becomes a reality. After $0.11 actual EPS reported by Simulations Plus, Inc. for the previous quarter, Wall Street now forecasts 18.18 % EPS growth.

Punch & Associates Investment Management Inc. holds 0.56% of its portfolio in Simulations Plus, Inc. for 400,990 shares. Ranger Investment Management L.P. owns 216,180 shares or 0.26% of their US portfolio. Moreover, Stanley has 0.26% invested in the company for 74,101 shares. The Rhode Island-based Whalerock Point Partners Llc has invested 0.26% in the stock. Ancora Advisors Llc, a Us-based fund reported 262,912 shares.

Since January 1, 0001, it had 0 insider purchases, and 4 selling transactions for $938,452 activity.

More recent Simulations Plus, Inc. (NASDAQ:SLP) news were published by: which released: “Simulations Plus Releases GastroPlusâ„¢ Version 9.6” on May 23, 2018. Also published the news titled: “Simulations Plus to Present at the Needham Emerging Technology Conference on May 16, 2018” on May 15, 2018.‘s news article titled: “US FDA Procures DILIsym Software License Package” with publication date: May 08, 2018 was also an interesting one.

Simulations Plus, Inc. (NASDAQ:SLP) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.